Bias due to missing SEER data in D'Amico risk stratification of prostate cancer

Journal of Urology

Volumn 187, Issue 6, 2012, Pages 2026-2031

  Elliott, Sean P ^a   Johnson, Dane P ^a   Jarosek, Stephanie L ^a   Konety, Badrinath R ^a   Adejoro, Oluwakayode O ^a   Virnig, Beth A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

bias (epidemiology); neoplasm staging; prostate; prostatic neoplasms; SEER program

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84861099933     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.01.070     Document Type: Article

References (17)

1. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era JAMA 280 1998 969
2. D.J. Hernandez, M.E. Nielsen, M. Han Contemporary evaluation of the D'Amico risk classification of prostate cancer Urology 70 2007 931
3. S.A. Boorjian, R.J. Karnes, L.J. Rangel Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354
4. Y.H. Shao, P.C. Albertsen, C.B. Roberts Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/mL Arch Intern Med 170 2010 1256
5. J.L. Worthington, S.M. Koroukian, G.S. Cooper Examining the characteristics of unstaged colon and rectal cancer cases Cancer Detect Prev 32 2008 251
6. H. Nathan, T.M. Pawlik Limitations of claims and registry data in surgical oncology research Ann Surg Oncol 15 2008 395
7. N. Howlader, L.A. Ries, D.G. Stinchcomb The impact of underreported Veterans Affairs data on National Cancer Statistics: analysis using population-based SEER registries J Natl Cancer Inst 101 2009 533
8. M.R. Cooperberg, D.J. Pasta, E.P. Elkin The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 2005 1938
9. S.P. Porten, D.A. Richardson, A.Y. Odisho Disproportionate presentation of high risk prostate cancer in a safety net health system J Urol 184 2010 1931
10. D.C. Miller, M.S. Litwin, J. Bergman Prostate cancer severity among low income, uninsured men J Urol 181 2009 579
11. J. Bynum, Y. Song, E. Fisher Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare J Am Geriatr Soc 58 2010 674
12. L.C. Walter, D. Bertenthal, K. Lindquist PSA screening among elderly men with limited life expectancies JAMA 296 2006 2336
13. V. Dudeja, E.B. Habermann, W. Zhong Guideline recommended gastric cancer care in the elderly: insights into the applicability of cancer trials to real world Ann Surg Oncol 18 2011 26
14. E.S. Fisher, D.E. Wennberg, T.A. Stukel The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care Ann Intern Med 138 2003 273
15. SEER Program Coding and Staging Manual 2004, Revision 1 National Cancer Institute 2004 http://seer.cancer.gov/tools/codingmanuals/historical.html Accessed September 2011
16. S.K. Shah, T.M. Fleet, V. Williams SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit J Urol 186 2011 855
17. D. Schreiber, J. Rineer, J.B. Yu Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort Cancer 116 2010 5757